Ulcerative colitis may be a risk factor for sensorineural hearing loss

Year 2021, Volume: 4 Issue: 3, 267 - 271, 21.05.2021

Ahmet Yozgat , Müjgan Gürler

https://doi.org/10.32322/jhsm.895387

Cited By: 1

Abstract

Introduction: Inflammatory bowel disease (IBD) is a chronic, idiopathic, relapsing, inflammatory disease of the gastrointestinal system, which includes two different diseases, namely ulcerative colitis (UC), and Crohn's disease (CD). Inner ear involvement of IBD, which causes sensorineural hearing loss (SNHL) is acute and bilateral and arises in a short period of weeks to months in the active period of the disease.
Methods: The present study included 53 IBD patients and 20 healthy control patients who were followed up in the gastroenterology outpatient clinic of Abant Izzet Baysal University Hospital between January and May 2020 and accepted to participate in the study. Tympanometry, otoscopy, and audiometry examinations were performed.
Results: There was no significant difference in terms of gender and age between the IBD and control groups. While there was no significant difference in air and bone conduction in both ears in patients with CD, there was a significant difference between both conductions in UC (p: 0.0001 in the left ear, p: 0.004 in the right ear). SNHL was detected in 45.2% (n:14) of UC patients and 13.6% (n:3) of CD patients in audiometry. Three of our UC patients had moderate, one had moderately severe, and one had profound hearing loss.
Conclusion: SNHL has been detected in a significant number of UC patients. Also, the hearing functions deteriorate significantly as the age of the patients and the duration of the disease increases. It should be recommended to evaluate UC patients over 40 years of age and with the long-term disease for SNHL.

Keywords

Sensorineural hearing loss, Ulcerative colitis,, Crohn’s Disease,, Audiometry

References

• Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol 2019; 13: 307-17.
• Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2015; 21: 1982-92.
• Garber A, Regueiro M. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etiopathogenesis, and management. Curr Gastroenterol Rep 2019; 21: 31.
• Fousekis FS, Saridi M, Albani E, et al. Ear involvement in inflammatory bowel disease: a review of the literature. J Clin Med Res 2018; 10: 609-14.
• Summers RW, Harker L. Ulcerative colitis and sensorineural hearing loss: is there a relationship? J Clin Gastroenterol 1982; 4: 251-2.
• Lobo DR, Garcia-Berrocal JR, Ramirez-Camacho R. New prospects in the diagnosis and treatment of immune-mediated inner ear disease. World J Methodol 2014; 4: 91-8.
• Akbayir N, Calis AB, Alkim C, al. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Dig Dis Sci 2005; 50: 1938-45.
• Karmody CS, Valdez TA, Desai U, Blevins NH. Sensorineural hearing loss in patients with inflammatory bowel disease. Am J Otolaryngol 2009; 30: 166-70.
• Casella G, Corbetta D, Zolezzi M, et al. Symptomatic sensorineural hearing loss in patients with ulcerative colitis. Tech Coloproctol 2015; 19: 729-31.
• Wengrower D, Koslowsky B, Peleg U, et al. Hearing Loss in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016; 61: 2027-32.
• Mohammed Vashist N, Samaan M, Mosli MH, et al. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev 2018; 1: CD011450.
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
• Clark JG. Uses and abuses of hearing loss classification. ASHA 1981; 23: 493-500.
• Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif 2011; 15: 91-105.
• Li X, Chen Y, Zhang G, Cui W. [Immune-mediated sensorineural hearing loss: prevalence and treatment strategies]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 34: 663-7.
• McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585-9.
• Atturo F, Colangeli R, Bandiera G, Barbara M, Monini S. Can unilateral, progressive or sudden hearing loss be immune-mediated in origin? Acta Otolaryngol 2017; 137: 823-8.
• Gonzalez JLT, Torres JR, Rios YH, Gonzalez MJV, Mendez Saenz MA, Soto-Galindo GA. Extended high-frequency audiometry as early detection of hearing loss in primary Sjogren syndrome. Clin Rheumatol 2017; 36: 2237-41.
• Di Stadio A, Ralli M. Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings. J Int Med Res 2017; 45: 1470-80.
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-33.
• Goodall AF, Siddiq MA. Current understanding of the pathogenesis of autoimmune inner ear disease: a review. Clin Otolaryngol 2015; 40: 412-9.
• Kalyoncu D, Urganci N, Calis AB, Ozbal A. Sensorineural hearing loss in pediatric patients with inflammatory bowel disease. Dig Dis Sci 2010; 55: 150-2.
• Polat E, Cinar Z, Keskindemirci G, et al. Assessment of hearing function in children with inflammatory bowel disease. J Int Adv Otol 2020; 16: 362-6.